Luigi Mangione due in court for arraignment as prosecutors seek death penalty
NEW YORK, April 25 (Reuters) - Luigi Mangione was due in Manhattan federal court on Friday to be asked for his plea to charges of gunning down health insurance executive Brian Thompson, a day after prosecutors formally stated their intent to seek the death penalty.
Mangione, 26, has pleaded not guilty to a separate set of New York state charges over the December 4 killing of Thompson, the former CEO of UnitedHealth Group's (UNH.N), opens new tab insurance unit UnitedHealthcare.
He is due to appear before U.S. District Judge Margaret Garnett for an arraignment at 1 p.m. EDT (1700 GMT).
The brazen shooting of Thompson outside a midtown Manhattan hotel, where the company had gathered for an investor conference, and the ensuing five-day manhunt, captivated Americans.
Authorities say the words "deny," "delay," and "depose" - a phrase that echoes tactics some accuse health insurers of using to avoid paying out claims - were found written on shell casings at the crime scene.
While public officials condemned the killing, some Americans have cheered Mangione, saying he drew attention to steep U.S. healthcare costs and the power of health insurers to refuse payment for some treatments.
In justifying their decision to seek the death penalty, prosecutors wrote in a Thursday night court filing that Mangione "presents a future danger because he expressed an intent to target an entire industry, and rally political and social opposition to that industry, by engaging in an act of lethal violence."
U.S. Attorney General Pam Bondi earlier this month announced that the Justice Department would seek the death penalty for Mangione. Thursday's court filing by the Manhattan U.S. Attorney's office formalized prosecutors' intent.
Mangione's lawyers have said Bondi's April 1 announcement was " unapologetically political" and breached government protocols for death penalty decisions.
If Mangione is convicted in the federal case, the jury would determine in a separate phase of the trial whether to recommend the death penalty. Any such recommendation must be unanimous, and the judge would be required to impose it.
Mangione is currently being held in federal lockup in Brooklyn.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
North Wales Chronicle
14 hours ago
- North Wales Chronicle
Rantzen warns peers not to hamper progress of assisted dying law
The Terminally Ill Adults (End Of Life) Bill cleared the Commons with a majority of 23 votes on Friday, but opponents have vowed to continue their resistance in the unelected chamber. The legislation could face a difficult passage through the Lords, with critics poised to table amendments to add further restrictions and safeguards to the Bill. Dame Esther told BBC Radio 4's Today: 'I don't need to teach the House of Lords how to do their job. They know it very well, and they know that laws are produced by the elected chamber. 'Their job is to scrutinise, to ask questions, but not to oppose. 'So yes, people who are adamantly opposed to this bill, and they have a perfect right to oppose it, will try and stop it going through the Lords, but the Lords themselves, their duty is to make sure that law is actually created by the elected chamber, which is the House of Commons who have voted this through.' Dame Esther, who turns 85 on Sunday and has terminal cancer, acknowledged the legislation would probably not become law in time for her to use it and she would have to 'buzz of to Zurich' to use the Dignitas clinic. Paralympian and crossbench peer Baroness Tanni Grey-Thompson told BBC Breakfast: 'We're getting ready for it to come to the Lord's and from my personal point of view, about amending it to make it stronger. 'We've been told it's the strongest Bill in the world, but to be honest, it's not very high bar for other legislation. 'So I do think there are a lot more safeguards that could be put in.' Conservative peer and disability rights campaigner Lord Shinkwin said the narrow Commons majority underlined the need for peers to take a close look at the legislation. He told Today 'I think the House of Lords has a duty to expose and to subject this Bill to forensic scrutiny' but 'I don't think it's a question of blocking it so much as performing our duty as a revising chamber'. He added: 'The margin yesterday was so close that many MPs would appreciate the opportunity to look at this again in respect of safeguards as they relate to those who feel vulnerable, whether that's disabled people or older people.' Labour MP Kim Leadbeater, who steered the Bill through the Commons, told the PA news agency she hoped peers would not seek to derail the legislation, which could run out of parliamentary time if it is held up in the Lords. She said: 'I would be upset to think that anybody was playing games with such an important and such an emotional issue.' A group of 27 Labour MPs who voted against the legislation said: 'We were elected to represent both of those groups and are still deeply concerned about the risks in this Bill of coercion of the old and discrimination against the disabled, people with anorexia and black, Asian and minority ethnic people, who we know do not receive equitable health care. 'As the Bill moves to the House of Lords it must receive the scrutiny that it needs. Not about the principles of assisted dying but its application in this deeply flawed Bill.' Meanwhile, one of the leading opponents of the Bill, Conservative Danny Kruger, said 'these are apocalyptic times'. In a series of tweets on Friday night, the East Wiltshire MP – who is at odds with his mother, Great British Bake Off judge Dame Prue Leith in her support for legalisation – accused assisted dying campaigners of being 'militant anti-Christians' who had failed to 'engage with the detail of the Bill'.
Rhyl Journal
15 hours ago
- Rhyl Journal
Rantzen warns peers not to hamper progress of assisted dying law
The Terminally Ill Adults (End Of Life) Bill cleared the Commons with a majority of 23 votes on Friday, but opponents have vowed to continue their resistance in the unelected chamber. The legislation could face a difficult passage through the Lords, with critics poised to table amendments to add further restrictions and safeguards to the Bill. Dame Esther told BBC Radio 4's Today: 'I don't need to teach the House of Lords how to do their job. They know it very well, and they know that laws are produced by the elected chamber. 'Their job is to scrutinise, to ask questions, but not to oppose. 'So yes, people who are adamantly opposed to this bill, and they have a perfect right to oppose it, will try and stop it going through the Lords, but the Lords themselves, their duty is to make sure that law is actually created by the elected chamber, which is the House of Commons who have voted this through.' Dame Esther, who turns 85 on Sunday and has terminal cancer, acknowledged the legislation would probably not become law in time for her to use it and she would have to 'buzz of to Zurich' to use the Dignitas clinic. Paralympian and crossbench peer Baroness Tanni Grey-Thompson told BBC Breakfast: 'We're getting ready for it to come to the Lord's and from my personal point of view, about amending it to make it stronger. 'We've been told it's the strongest Bill in the world, but to be honest, it's not very high bar for other legislation. 'So I do think there are a lot more safeguards that could be put in.' Conservative peer and disability rights campaigner Lord Shinkwin said the narrow Commons majority underlined the need for peers to take a close look at the legislation. He told Today 'I think the House of Lords has a duty to expose and to subject this Bill to forensic scrutiny' but 'I don't think it's a question of blocking it so much as performing our duty as a revising chamber'. He added: 'The margin yesterday was so close that many MPs would appreciate the opportunity to look at this again in respect of safeguards as they relate to those who feel vulnerable, whether that's disabled people or older people.' Labour MP Kim Leadbeater, who steered the Bill through the Commons, told the PA news agency she hoped peers would not seek to derail the legislation, which could run out of parliamentary time if it is held up in the Lords. She said: 'I would be upset to think that anybody was playing games with such an important and such an emotional issue.' A group of 27 Labour MPs who voted against the legislation said: 'We were elected to represent both of those groups and are still deeply concerned about the risks in this Bill of coercion of the old and discrimination against the disabled, people with anorexia and black, Asian and minority ethnic people, who we know do not receive equitable health care. 'As the Bill moves to the House of Lords it must receive the scrutiny that it needs. Not about the principles of assisted dying but its application in this deeply flawed Bill.' Meanwhile, one of the leading opponents of the Bill, Conservative Danny Kruger, said 'these are apocalyptic times'. In a series of tweets on Friday night, the East Wiltshire MP – who is at odds with his mother, Great British Bake Off judge Dame Prue Leith in her support for legalisation – accused assisted dying campaigners of being 'militant anti-Christians' who had failed to 'engage with the detail of the Bill'.
Scottish Sun
15 hours ago
- Scottish Sun
Are YOU eligible for free fat jabs on the NHS? As GPs start dishing out Mounjaro – all you need to know
Our round-up also reveals what you need to do if your GP denies you a fat jab prescription and advice if you're intending on buying them privately NATIONAL JAB SERVICE Are YOU eligible for free fat jabs on the NHS? As GPs start dishing out Mounjaro – all you need to know THEY are arguably the biggest medical breakthrough of recent times. And from Monday, so-called 'fat jabs' will be made available to many more Brits on the NHS. Advertisement 5 From Monday, GPs will begin prescribing the weight-loss jab Mounjaro in the first anti-obesity rollout of its kind Credit: Getty 5 Health chiefs hope the Mounjaro rollout will turn the tide on England's obesity crisis Credit: Getty In what marks the dawn of a new era, GPs will begin prescribing the weight-loss jab Mounjaro in the first anti-obesity rollout of its kind. More than three million people are thought to be eligible for tirzepatide - the active drug in Mounjaro - the strongest jab on the market. Health chiefs hope it will turn the tide on England's obesity crisis which has seen rates double since the 1990s. Advertisement Injections including Ozempic and Wegovy have previously only been available for type 2 diabetes or through specialist slimming clinics. Family doctors will now be encouraged to prescribe them in a bid to get more people on the meds. Experts hope widespread use will slash work sick days and boost the economy, while reducing rates of cancer, heart disease and dementia. But demand for the drugs is already huge and NHS clinics cannot dish them out fast enough. Here is everything you need to know as the rollout begins: Advertisement What is Mounjaro and what has it been used for so far? 5 Studies found Mounjaro caused 20 per cent weight loss over 18 months Credit: Reuters FOR anyone who has missed the frenzy, Mounjaro, aka tirzepatide, is the newest weight loss injection used on the NHS. It has been around since 2022 and triggers fullness hormones in the gut to prevent hunger and over-eating. This works the same as older jabs Wegovy and Ozempic, all known as GLP-1 agonists, but a recent trial showed it is more effective. A head-to-head study in the New England Journal of Medicine found Mounjaro caused 20 per cent weight loss over 18 months, while semaglutide – the active ingredient in Wegovy and Ozempic – led to 14 per cent. Advertisement All the jabs were originally invented to treat type 2 diabetes but trials found they could also cause major weight loss. Pharma firms have cashed in on the discovery and UK prescriptions have skyrocketed. NHS prescriptions of Mounjaro in England surged from just 3,300 in 2023 to 1.1million last year, and more than a million people are estimated to be buying it online. Weight Loss Jabs - Pros vs Cons Who will be eligible in the new rollout? THE new rollout starting on Monday will allow GPs to prescribe tirzepatide for weight loss, starting with those patients whose weight places them at greatest health risk. Top of the list will be those with a body mass index (BMI) of 40 or higher and four weight-related health conditions. Advertisement A BMI of 40 is roughly equal to weighing 16st (102kg) for an average height 5'3' woman, or 19st 6lbs (123kg) for an average 5'9' man. Weight-related conditions include high cholesterol, high blood pressure, prediabetes, type 2 diabetes, obstructive sleep apnoea and heart disease. Patients will likely be expected to have tried diet and exercise first before being offered a jab. Many are likely to miss out, as some 13.5million adults in England are obese but only 3.4million are estimated to be eligible in the rollout. How will the rollout be run and what is new? 5 Wes Streeting wants a more widespread use of the drugs but patients must also receive check-ups Credit: Getty Advertisement WHAT'S new is that the rollout will be the first run by NHS primary care, led by GP surgeries. In theory this should make life easier for patients – but GPs will not be able to meet the huge demand. NHS bosses have admitted it will take a staggering 12 years to treat everyone who is eligible. Just 220,000 extra people are likely to get Mounjaro by 2028. Private prescriptions, costing about £100-£150 per month, already vastly outnumber that and are rising. Advertisement Health Secretary Wes Streeting wants a faster rollout and more widespread use of the drugs but patients must also receive regular check-ups and lifestyle help. Officials are investigating whether they can dish them out through pharmacies or the NHS app to take a load off GPs. Professor Jason Halford, of the European Association for the Study of Obesity, said: 'These drugs have the potential to help millions. 'If the government and NHS are serious about prevention they need to reconsider their position on the speed of the rollout of these drugs.' Professor John Deanfield, a heart doctor at University College London, added: 'These drugs provide a real opportunity to delay many diseases of ageing all at the same time and potentially transform society. Advertisement 'I hope it won't take 10 years to do something that is so needed.' What if my GP says no? 5 If you are eligible but your GP denies you a prescription, you may be able to ask for a referral to specialist weight management services Credit: Getty MANY people are expected to miss out and some surgeries are already pouring cold water on patients' hopes. Fairhill Medical Practice in Kingston upon Thames said: 'Once we are able to prescribe weight loss injections they will be offered to those with the highest medical need only, which may mean that a lot of patients will be disappointed.' Millions who meet the prescription criteria will simply have to be denied the drugs because doctors are so busy. Advertisement On top of everything else England's 6,300 doctors' surgeries have to deal with, they do not have the capacity to offer the necessary long-term supervision for millions more people at once. Experts reckon private prescriptions will rocket even more as frustrated patients give up waiting. If you are eligible but your GP denies you a prescription, you may be able to ask for a referral to specialist weight management services. Known as tier 2 and tier 3 weight management services, they may prescribe the jabs after other weight loss attempts. Many people are expected to find it easier to go private, with the injections widely available from high street pharmacies like Boots, Superdrug, and even Asda. Advertisement Olivier Picard, of the National Pharmacy Association, said: 'NHS provision won't meet demand straight away, so we fully expect that many people will continue seeking it privately.' Advice for people buying them privately BUYING the drugs online might seem like the faster fix – but buyer beware. Slimming success stories are everywhere but so, too, are tales of horror. Many patients have been duped by dodgy sellers, suffered severe side effects or even died after taking jabs they bought online. Bargain prices, easy tick-box applications, or prescriptions with no follow-up, should all be red flags to online shoppers. Advertisement Many pharmacies have been rapped for giving them away to people who do not meet the obesity criteria, potentially putting their health at risk. Dose strength is partly based on size and pretending you are fatter than you are could mean you end up with a medication too strong for your body, raising the risk of serious side effects. The most common side effects from the injections include feeling sick, vomiting, diarrhoea or other gut troubles. If not treated properly people can suffer more serious impacts like dehydration, gallstones, pancreatitis or allergic reactions – and more than 100 deaths in the UK have so far been linked to the jabs. The General Pharmaceutical Council issued new rules in February to say that all pharmacies must verify a patient's height and weight, and conduct at least a video call – if not face-to-face appointment – before prescribing weight loss injections. Advertisement Dr Emily Pegg, associate vice president at Lilly, which makes Mounjaro, said: 'This is still a prescription-only medicine, should only be prescribed by a registered healthcare professional and needs to be dispensed by a registered pharmacy. 'It is not something that people should be able to buy by just going out and going on to a social media site and clicking a button and it gets delivered to them. 'That is not appropriate and is probably illegal. 'Patient safety is a high priority.' Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. Future of fat jabs WHILE the Mounjaro rollout is expected to kick off with a whimper and not a bang, it is hoped it will mark the beginning of a new era in weight loss medicine. Advertisement Brits have been getting gradually fatter for decades and no medication or government policy has managed to beat the bulge. The drugs appear super-effective, reasonably priced and relatively safe, and could help millions slim down after failed diets. They are expected to reduce the risks of type 2 diabetes, cancer and dementia. And studies increasingly show they improve health in other ways on top of weight loss, too, reducing the risk of heart attacks and strokes. NHS medical director, Professor Sir Stephen Powis, believes they could one day be as transformative as cholesterol-lowering statins, which have slashed heart attacks since they were rolled out decades ago. Advertisement Prof Powis said: 'I think over time it's highly likely that these drugs will become more widespread. 'I think there will be a combination of increased evidence of positive outcomes and costs dropping, and we will learn better how to deploy them. 'This is very exciting – we're in the foothills of learning how to use them.'
